JP2004502756A5 - - Google Patents

Download PDF

Info

Publication number
JP2004502756A5
JP2004502756A5 JP2002509087A JP2002509087A JP2004502756A5 JP 2004502756 A5 JP2004502756 A5 JP 2004502756A5 JP 2002509087 A JP2002509087 A JP 2002509087A JP 2002509087 A JP2002509087 A JP 2002509087A JP 2004502756 A5 JP2004502756 A5 JP 2004502756A5
Authority
JP
Japan
Prior art keywords
phenyl
halogen
substituted
alkoxy
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002509087A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004502756A (ja
Filing date
Publication date
Priority claimed from GB0017174A external-priority patent/GB0017174D0/en
Priority claimed from GB0023326A external-priority patent/GB0023326D0/en
Application filed filed Critical
Priority claimed from PCT/EP2001/007941 external-priority patent/WO2002004420A1/en
Publication of JP2004502756A publication Critical patent/JP2004502756A/ja
Publication of JP2004502756A5 publication Critical patent/JP2004502756A5/ja
Pending legal-status Critical Current

Links

JP2002509087A 2000-07-12 2001-07-10 Ccr−3インヒビターとして使用するためのピペリジン化合物 Pending JP2004502756A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0017174A GB0017174D0 (en) 2000-07-12 2000-07-12 Organic compounds
GB0023326A GB0023326D0 (en) 2000-09-22 2000-09-22 Organic compounds
PCT/EP2001/007941 WO2002004420A1 (en) 2000-07-12 2001-07-10 Piperidine coumpounds for use as ccr-3 inhibitors

Publications (2)

Publication Number Publication Date
JP2004502756A JP2004502756A (ja) 2004-01-29
JP2004502756A5 true JP2004502756A5 (OSRAM) 2005-02-03

Family

ID=26244644

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002509087A Pending JP2004502756A (ja) 2000-07-12 2001-07-10 Ccr−3インヒビターとして使用するためのピペリジン化合物

Country Status (25)

Country Link
US (1) US6670379B2 (OSRAM)
EP (1) EP1303488B1 (OSRAM)
JP (1) JP2004502756A (OSRAM)
KR (1) KR20030036603A (OSRAM)
CN (1) CN1184204C (OSRAM)
AR (1) AR031597A1 (OSRAM)
AT (1) ATE447553T1 (OSRAM)
AU (2) AU2001281972B2 (OSRAM)
BR (1) BR0112456A (OSRAM)
CA (1) CA2412941C (OSRAM)
CZ (1) CZ200375A3 (OSRAM)
DE (1) DE60140366D1 (OSRAM)
ES (1) ES2334886T3 (OSRAM)
HU (1) HUP0301341A2 (OSRAM)
IL (1) IL153661A0 (OSRAM)
MX (1) MXPA02012848A (OSRAM)
MY (1) MY126139A (OSRAM)
NO (1) NO324760B1 (OSRAM)
NZ (1) NZ523414A (OSRAM)
PE (1) PE20020616A1 (OSRAM)
PL (1) PL358673A1 (OSRAM)
PT (1) PT1303488E (OSRAM)
SK (1) SK272003A3 (OSRAM)
TW (1) TWI227231B (OSRAM)
WO (1) WO2002004420A1 (OSRAM)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19952147A1 (de) * 1999-10-29 2001-05-03 Boehringer Ingelheim Pharma Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
JP4199539B2 (ja) * 2000-10-09 2008-12-17 ノバルティス アクチエンゲゼルシャフト Ccr−3受容体アンタゴニストとしてのn−(4−アリールオキシピペリジン−1−イルアルキル)桂皮酸アミド
GB0114699D0 (en) 2001-06-15 2001-08-08 Novartis Ag Organic compounds
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
UY35464A (es) 2013-03-15 2014-10-31 Araxes Pharma Llc Inhibidores covalentes de kras g12c.
MX364438B (es) * 2013-03-15 2019-04-26 Araxes Pharma Llc Inhibidores covalentes de kras g12c.
TWI659021B (zh) 2013-10-10 2019-05-11 亞瑞克西斯製藥公司 Kras g12c之抑制劑
EA201792214A1 (ru) 2015-04-10 2018-01-31 Араксис Фарма Ллк Соединения замещенного хиназолина
JP6789239B2 (ja) 2015-04-15 2020-11-25 アラクセス ファーマ エルエルシー Krasの縮合三環系インヒビターおよびその使用の方法
US10144724B2 (en) 2015-07-22 2018-12-04 Araxes Pharma Llc Substituted quinazoline compounds and methods of use thereof
US10689356B2 (en) 2015-09-28 2020-06-23 Araxes Pharma Llc Inhibitors of KRAS G12C mutant proteins
WO2017058768A1 (en) 2015-09-28 2017-04-06 Araxes Pharma Llc Inhibitors of kras g12c mutant proteins
EP3356354A1 (en) 2015-09-28 2018-08-08 Araxes Pharma LLC Inhibitors of kras g12c mutant proteins
WO2017058915A1 (en) 2015-09-28 2017-04-06 Araxes Pharma Llc Inhibitors of kras g12c mutant proteins
EP3356347A1 (en) 2015-09-28 2018-08-08 Araxes Pharma LLC Inhibitors of kras g12c mutant proteins
US10882847B2 (en) 2015-09-28 2021-01-05 Araxes Pharma Llc Inhibitors of KRAS G12C mutant proteins
WO2017058728A1 (en) 2015-09-28 2017-04-06 Araxes Pharma Llc Inhibitors of kras g12c mutant proteins
CA3005089A1 (en) 2015-11-16 2017-05-26 Araxes Pharma Llc 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof
US10646488B2 (en) 2016-07-13 2020-05-12 Araxes Pharma Llc Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof
JP2019529484A (ja) 2016-09-29 2019-10-17 アラクセス ファーマ エルエルシー Kras g12c変異体タンパク質の阻害剤
CN110312711A (zh) 2016-10-07 2019-10-08 亚瑞克西斯制药公司 作为ras抑制剂的杂环化合物及其使用方法
JP7327802B2 (ja) 2017-01-26 2023-08-16 アラクセス ファーマ エルエルシー 縮合ヘテロ-ヘテロ二環式化合物およびその使用方法
US11136308B2 (en) 2017-01-26 2021-10-05 Araxes Pharma Llc Substituted quinazoline and quinazolinone compounds and methods of use thereof
WO2018140599A1 (en) 2017-01-26 2018-08-02 Araxes Pharma Llc Benzothiophene and benzothiazole compounds and methods of use thereof
US11274093B2 (en) 2017-01-26 2022-03-15 Araxes Pharma Llc Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
EP3573971A1 (en) 2017-01-26 2019-12-04 Araxes Pharma LLC 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer
US10745385B2 (en) 2017-05-25 2020-08-18 Araxes Pharma Llc Covalent inhibitors of KRAS
JP2020521740A (ja) 2017-05-25 2020-07-27 アラクセス ファーマ エルエルシー 変異体kras、hrasまたはnrasの調節因子としてのキナゾリン誘導体
TW201906832A (zh) 2017-05-25 2019-02-16 美商亞瑞克西斯製藥公司 用於癌症治療之化合物及其使用方法
BR112021001709A2 (pt) 2018-08-01 2021-05-04 Araxes Pharma Llc compostos espiro heterocíclicos e métodos de uso dos mesmos para o tratamento de câncer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1003514A4 (en) * 1997-07-25 2000-10-11 Merck & Co Inc CYCLIC AMINE MODULATORS OF CHEMOKIN RECEPTORS
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
US6339087B1 (en) 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
ATE280157T1 (de) 1998-11-17 2004-11-15 Hoffmann La Roche 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
AU3126700A (en) 1998-12-18 2000-07-03 Du Pont Pharmaceuticals Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
SK11822001A3 (sk) * 1999-03-26 2002-09-10 Astrazeneca Ab Modulátory chemokínovej aktivity, spôsoby ich prípravy, farmaceutické kompozície s ich obsahom a ich použitie v terapii

Similar Documents

Publication Publication Date Title
JP2004502756A5 (OSRAM)
CA2412941A1 (en) Piperidine compounds for use as ccr-3 inhibitors
CA2694270A1 (en) Substituted aryloxazoles and the use thereof
CA2671127A1 (en) Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof
JP2004501930A5 (OSRAM)
CA2681972A1 (en) Substituted dibenzoic acid derivatives and use thereof
CN109983007A (zh) 酰胺类衍生物抑制剂及其制备方法和应用
RU2007148994A (ru) Композиции и способы лечения заболевания сетчатки
CA2471642A1 (en) 6-fluorobicyclo[3.1.0]hexane derivatives
CA2626477A1 (en) Dicarboxylic acid derivatives and their use
RU2018120242A (ru) Хинолиновые соединения, способы их получения и их применения в качестве лекарственного средства, ингибирующего транспортер уратов
CA2671071A1 (en) Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof
CN114401964A (zh) 一类具有brd4抑制活性的化合物、其制备方法及用途
JP2010510999A5 (OSRAM)
RU2003117476A (ru) Аминотиазолы и их применение в качестве антагонистов рецептора аденозина
JP2007516206A5 (OSRAM)
JP2010501478A5 (OSRAM)
JP2009507896A5 (OSRAM)
CA2492718A1 (en) Prodrugs of proton pump inhibitors
JP2010516701A5 (OSRAM)
CA2626451A1 (en) Cyclopropylacetic acid derivatives and use thereof
CA2626454A1 (en) Difluorophenol derivatives and their use
JP2002514649A5 (OSRAM)
CA2578596C (en) Substituted phenylaminothiazoles and their use
JP2006523698A5 (OSRAM)